Patent application number | Description | Published |
20080242698 | Organic Compounds - The invention relates to novel diamines of the formula | 10-02-2008 |
20090005363 | Organic Compounds - The present invention relates to novel nicotinic acid derivatives, of formula (I) | 01-01-2009 |
20090137804 | Compounds and Compositions as Protein Kinase Inhibitors - The invention relates to compounds of formula (I) | 05-28-2009 |
20090286827 | NOVEL BI-ARYL AMINES - The present invention relates to novel bi-aryl amines of formula (I) and to pharmaceutically acceptable prodrugs, salts, solvates, hydrates, and N-oxides thereof and to pharmaceutical compositions comprising them, methods of their use, and methods of their preparation. | 11-19-2009 |
20100069407 | CXCR2 inhibitors - The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease. | 03-18-2010 |
20100152205 | CXCR2 INHIBITORS - The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease. | 06-17-2010 |
20130012476 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention relates to compounds of formula (I) | 01-10-2013 |
20130012704 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention relates to compounds of formula (I) | 01-10-2013 |
20150335646 | Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones - The invention relates to compound of the formula (I); or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it. | 11-26-2015 |